Received a "Study May Proceed” letter from the FDA to evaluate amezalpat in combination with atezolizumab (TECENTRIQ®) and ...

As companies continue to adopt AI technology and tools, developing employees' AI capabilities should be a key priority.

While focusing on building and maintaining effective teams is an activity that successful leaders are constantly focused on, ...

CCI staff share recent surveys, reports and analysis on risk, compliance, governance, infosec and leadership issues. Share ...

The World Economic Forum currently places Australia 24th among 146 countries, down from 15th in 2006. At the current rate of ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...

Tenet's large debt balance creates an ongoing servicing need that could be exacerbated by a large contraction in operating profitability. In such a scenario, Tenet may have trouble refinancing at ...

The newly released Insights Report, “Improvement in Safety Culture Linked to Better Patient and Staff Outcomes,” highlights ...

Once it’s released, the Cradle-to-Career data system could reshape parents’ and students’ decisions and lead to significant ...